background
coronavirus
cov
larg
ribonucl
acid
rna
virus
caus
primarili
respiratori
diseas
human
novel
human
coronaviru
subsequ
name
middl
east
respiratori
syndrom
coronaviru
merscov
first
report
saudi
arabia
septemb
increas
number
infect
death
merscov
develop
rapid
reliabl
kit
crucial
prevent
spread
merscov
studi
present
two
realtim
reversetranscript
polymeras
chain
reaction
rrtpcr
assay
inhous
rapid
sensit
diagnost
test
merscov
detect
region
upstream
envelop
gene
upe
open
read
frame
orf
respect
initi
screen
final
confirm
merscov
infect
recommend
world
health
organ
experiment
studi
acquir
patient
sampl
difficult
thu
accord
recommend
standard
protocol
synthes
rna
sequenc
upe
gene
templat
signatur
taqman
baseddiagnost
rrtpcr
assay
carri
use
synthet
gene
detect
merscov
research
also
inaugur
cellfre
system
transcrib
rna
sequenc
use
dna
templat
synthes
upe
base
onestep
rrtpcr
assay
optim
test
sever
time
via
differ
synthet
rna
valid
result
highli
success
sensit
obtain
upe
fewer
ten
copi
rna
templat
per
reaction
fewer
copi
per
reaction
studi
show
develop
rrtpcr
assay
rapid
reliabl
reproduc
specif
sensit
simpl
tool
detect
merscov
final
kit
consist
two
assay
signatur
control
assembl
distribut
public
health
laboratori
iran
support
intern
merscov
surveil
public
health
respons
coronavirus
cov
envelop
singlestrand
positivesens
ribonucl
acid
rna
virus
widespread
found
mani
speci
mice
hors
whale
bird
cat
dog
pig
human
develop
infect
lead
addit
complic
includ
respiratori
tract
diseas
organ
dysfunct
particularli
renal
failur
immun
suppress
enter
neurolog
hepat
diseas
major
patient
typic
symptom
fever
without
cough
breath
difficulti
middl
east
respiratori
syndrom
coronaviru
merscov
new
unknown
origin
respiratori
viru
genotyp
phenotyp
divers
thu
viru
mutat
increas
virul
even
caus
tissu
tropism
highfrequ
mortal
rate
around
median
age
major
identifi
case
affect
viru
year
littl
known
behavior
human
known
maintain
circul
four
differ
human
coronavirus
hcov
global
popul
level
part
spectrum
agent
caus
common
cold
sever
acut
respiratori
syndrom
sar
cov
constitut
fifth
hcov
circul
limit
time
viru
appear
human
caus
outbreak
affect
least
peopl
symptom
match
clinic
pictur
acut
primari
viral
pneumonia
merscov
novel
coronaviru
detect
first
time
septemb
saudi
arabia
area
heavili
impact
viru
present
april
june
case
infect
hcov
report
saudi
arabia
patient
die
fatal
rate
high
viru
merscov
caus
sever
acut
respiratori
infect
human
subsequ
merscov
report
countri
includ
tunisia
unit
arab
emir
itali
unit
kingdom
germani
franc
qatar
first
case
merscov
infect
report
iran
two
case
kerman
citi
southeast
iran
viru
kill
one
woman
appear
new
case
view
risk
merscov
transmiss
human
sever
infect
observ
among
elderli
consider
concern
viru
although
case
report
annual
around
case
may
morbid
mortal
rate
infect
alarm
unfortun
present
specif
treatment
effect
drug
deadli
diseas
vaccin
absenc
effect
treatment
appropri
infect
control
includ
rapid
diagnost
isol
patient
use
strategi
prevent
transmiss
spread
infecti
agent
current
realtim
reversetranscript
polymeras
chain
reaction
rrtpcr
assay
use
detect
merscov
respiratori
blood
stool
sampl
patient
realtim
rtpcr
assay
highli
sensit
abl
detect
virus
even
low
copi
number
aim
research
present
two
rrtpcr
assay
inhous
rapid
sensit
diagnost
test
merscov
detect
region
upstream
envelop
gene
upe
open
read
frame
orf
respect
initi
screen
final
confirm
merscov
infect
accord
world
health
organ
recommend
experiment
studi
sequenc
obtain
nation
center
biotechnolog
inform
ncbi
genbank
access
number
rotterdam
viru
isol
term
hcovemc
synthes
eurofin
genom
germani
serv
templat
assay
design
dna
templat
upe
novel
human
coronaviru
amplifi
confirm
use
correspond
realtim
pcr
specif
probe
primer
forward
revers
signatur
target
region
upe
synthes
eurofin
genom
germani
vector
pgh
clone
vector
subclon
roch
express
vector
use
hindiii
restrict
site
result
present
subsequ
transcrib
rna
prepar
viral
templat
use
transcript
kit
roch
synthes
singlestrand
rna
step
contamin
rnase
must
avoid
usual
diethylpyrocarbon
depc
treatment
use
dispos
plasticwar
wear
glove
etc
dnase
digest
rna
transcript
purifi
use
roch
high
pure
viral
rna
kit
quantifi
ultraviolet
uv
light
spectroscopi
dna
content
remain
stage
due
remov
result
common
realtim
pcr
assay
neg
result
present
wherea
result
realtim
reversetranscript
polymeras
chain
reaction
rrtpcr
assay
posit
novel
inhous
onestep
rrtpcr
assay
develop
use
quantifast
rtpcr
kit
qiagen
hilden
germani
corbet
rotorgen
qiagen
germani
thermal
cycl
includ
minut
follow
minut
cycl
second
mention
common
onestep
realtim
rtpcr
kit
formul
applic
probe
provid
satisfactori
result
default
reaction
mix
composit
suggest
manufactur
iran
red
crescent
med
j
confirmatori
assay
condit
describ
upe
rrtpcr
albeit
primer
probe
sequenc
differ
assay
perform
forward
primer
ttcgatgttgagggtgctcat
revers
primer
tcacaccagttgaaaatcctaattg
well
specif
probe
fam
n
n
n
tetramethylrhodamin
tamra
target
gene
overlap
known
pancov
assay
note
two
transcrib
candid
signatur
target
region
upe
use
assay
difficulti
acquir
patient
sampl
accord
recommend
two
rna
sequenc
also
synthes
eurofin
genom
germani
use
rna
control
standard
rna
optim
two
assay
prepar
serial
dilut
evalu
sensit
rna
dilut
prepar
rnasefre
water
limit
detect
merscov
upe
gene
serial
dilut
quantifi
standard
upe
rna
prepar
mm
te
buffer
test
upe
assay
signatur
replic
highest
dilut
upe
rna
replic
posit
defin
limit
detect
lod
upe
assay
b
limit
detect
merscov
gene
sensit
evalu
optim
test
candid
probe
primer
signatur
assay
serial
dilut
merscov
quantifi
standard
rna
separ
reaction
compar
tenfold
serial
dilut
merscov
rna
prepar
buffer
test
replic
highest
dilut
rna
replic
posit
defin
limit
detect
lod
assay
volum
use
two
realtim
rtpcr
assay
upe
reactiv
differ
merscov
strain
silico
predict
addit
demonstr
reactiv
rrtpcr
assay
merscov
strain
primerprob
sequenc
evalu
addit
eight
recent
publish
genom
sequenc
seven
patient
collect
dna
templat
synthes
upe
novel
human
coronaviru
amplifi
confirm
use
gelbas
tradit
pcr
figur
common
realtim
pcr
correspond
specif
probe
primer
forward
revers
signatur
figur
confirmatori
onestep
rrtpcr
assay
perform
synthet
standard
rna
contain
upe
signatur
use
specif
probe
primer
figur
test
initi
screen
merscov
infect
bebecaus
highli
sensit
assay
result
rna
transcript
contain
upe
signatur
confirmatori
also
similar
synthet
standard
rna
result
present
confirmatori
onestep
rrtpcr
assay
perform
synthet
standard
rna
contain
signatur
use
specif
probe
primer
figur
test
conclus
detect
merscov
infect
bebecaus
highli
specif
assay
result
rna
transcript
contain
signatur
confirmatori
also
similar
synthet
standard
rna
result
present
prepar
serial
dilut
standard
rna
evalu
analyt
sensit
assay
figur
shown
tabl
stage
sensit
minimum
detect
limit
determin
gene
done
separ
realtim
rtpcr
assay
show
differ
sensit
upe
target
region
serial
dilut
contain
copi
standard
rna
per
reaction
analyz
use
realtim
rtpcr
assay
highest
dilut
upe
rna
replic
posit
defin
limit
detect
lod
upe
assay
minimum
detect
limit
assay
signatur
fewer
ten
copi
standard
rna
per
reaction
tabl
higher
dilut
evalu
b
limit
detect
lod
merscov
gene
serial
dilut
contain
copi
standard
rna
per
reaction
analyz
use
realtim
rtpcr
assay
highest
dilut
rna
replic
posit
defin
limit
detect
lod
assay
minimum
detect
limit
assay
signatur
fewer
copi
standard
rna
per
reaction
tabl
dilut
copi
standard
rna
per
reaction
evalu
sinc
human
coronaviru
hcov
term
sarscov
caus
fatal
southeast
asia
spread
anoth
cov
term
merscov
caus
consider
concern
intern
commun
saudi
arabia
main
center
spread
mer
import
islam
countri
larg
number
peopl
travel
saudi
arabia
hajj
pilgrimag
annual
million
world
muslim
travel
saudi
arabia
order
perform
hajj
ritual
amass
peopl
result
spread
infect
diseas
transmiss
differ
countri
unfortun
present
specif
treatment
effect
drug
vaccin
deadli
infect
iran
red
crescent
med
j
absenc
effect
treatment
appropri
infect
control
includ
rapid
diagnost
isol
patient
use
strategi
prevent
transmiss
spread
infecti
agent
develop
rapid
accur
diagnost
kit
facilit
earlystag
detect
infect
individu
respiratori
symptom
return
hajj
reenter
countri
prevent
spread
infect
best
method
detect
merscov
recommend
realtim
rtpcr
assay
upe
gene
initi
screen
diseas
gene
final
confirm
merscov
infect
notabl
tradit
gelbas
rtpcr
method
requir
amplif
thermo
cycler
cdna
prepar
via
rt
process
product
analysi
electrophoresi
gel
timeconsum
labori
elimin
need
postamplif
product
process
realtim
rtpcr
method
enabl
shorten
turnaround
time
report
result
critic
determin
isol
suspect
case
patient
contact
trace
realtim
rtpcr
assay
sensit
rapid
autom
also
high
reproduc
sinc
need
postpcr
process
elimin
prevent
carryov
contamin
taqman
probebas
realtim
rtpcr
assay
provid
confid
identif
target
gene
due
specif
probe
also
reduc
risk
laboratori
product
contamin
amplif
reaction
detect
pcr
product
perform
singl
tube
despit
advantag
rrtpcr
assay
techniqu
twostep
step
revers
transcript
rt
rna
cdna
prepar
step
realtim
pcr
studi
develop
novel
onestep
rrtpcr
assay
base
specif
taqman
probe
instead
tradit
twostep
rrtpcr
assay
enabl
step
accomplish
singl
step
increas
sensit
assay
afford
econom
addit
advantag
mention
sinc
acquir
patient
sampl
complet
viral
genom
difficult
accord
recommend
standard
protocol
instead
synthes
rna
sequenc
upe
gene
templat
signatur
taqmanbas
diagnost
rrtpcr
assay
carri
use
synthet
gene
detect
merscov
research
also
inaugur
cellfre
system
transcrib
rna
use
synthes
dna
templat
previous
shown
stage
sensit
determin
gene
done
separ
realtim
rtpcr
assay
show
differ
sensit
upe
target
region
notabl
assay
lower
sensit
upe
assay
studi
show
develop
novel
onestep
rrtpcr
assay
base
specif
taqman
probe
rapid
reliabl
reproduc
specif
sensit
simpl
molecular
method
detect
merscov
final
kit
consist
two
assay
signatur
control
assembl
distribut
public
health
laboratori
iran
support
intern
merscov
surveil
public
health
respons
